Despite what you may have heard about drug pricing and expenses getting out of hand, net spending growth actually fell in the U.S. last year. After discounts, pharmaceutical spending increased 4.8% in 2016, down from 8.9% growth recorded in 2015.
FDA issued Warning Letters addressed to 14 U.S. – based companies illegally selling more than 65 products that fraudulently claim to prevent, diagnose, treat or cure cancer.
Stanford University scientists have identified a protein that, given before an injury, boosts stem cell response and improves healing. “Priming” with this protein, called hepatocyte growth factor activator (HGFA), could eventually speed recovery in cases where injury is expected, such as patients undergoing surgery.
A tougher vaccine law in California that prohibits parents from using personal beliefs to exempt their kids boosted coverage rates significantly in the first school year after its implementation.
One of the most active research endeavors in immuno-oncology involves engineering human viruses into weapons that can fight cancer. Now, a group of scientists at the University of Parma in Italy is looking to another source of potentially potent cancer-killing viruses: cows.
Patients in the U.K. face yet another barrier to access as a tough budget situation has forced the country’s healthcare system to consider rationing costly drugs. Among them are medicines from Johnson & Johnson, Merck and Roche.
It is hard to imagine this right now; however, a wearable device that still does not even support Spotify and only last fall adopted built-in GPS technology could soon save lives. Literally, not the kind of life-altering advertising propaganda you may see bandied about at a glitzy Apple hardware event.
Forged clinical trial data have hurt China’s reputation, and the country’s administrative and judicial branches are proposing new actions against such activities in a seemingly synchronized move, and criminal charges are on the table.
University of Utah researchers have developed “smart glasses” that mimic the function of the eye’s lens and automatically focus on what an individual is looking at.
For an Agency that has announced its intention to release more than 100 draft guidance documents in 2017, the US Food and Drug Administration (FDA) is off to a slow start following President Donald Trump’s inauguration.